title: Why do our patients get chemotherapy until the end of life?
authors.affiliation: Instituto Português de Oncologia and Instituto Gulbenkian de Ciência (Gulbenkian Program for Advanced Medical Education), Lisboa, Portugal. Electronic address: sbraga@igc.gulbenkian.pt.
authors.forename: S
authors.initials: S
authors.lastname: Braga
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077216:Carcinoma, Ovarian Epithelial; D005260:Female; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D010166:Palliative Care / Q000379:methods*; D013727:Terminal Care / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents